-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
2'-Deoxy-4'-ethynyl-2-fluoroadenosine
Category | Human immunodeficiency Virus (HIV) |
CAS | 865363-93-5 |
Description | Islatravir (MK-8591) is a potent anti-HIV-1 agent, acting as a nucleoside reverse transcriptase inhibitor, with EC50s of 0.068 nM, 3.1 nM and 0.15 nM for HIV-1 (WT), HIV-1 (M184V), HIV-1 (MDR), respectively. |
Product Information
Synonyms | EFdA; 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine |
IUPAC Name | (2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-ethynyl-2-(hydroxymethyl)oxolan-3-ol |
Molecular Weight | 293.25 |
Molecular Formula | C12H12FN5O3 |
Canonical SMILES | C#CC1(C(CC(O1)N2C=NC3=C(N=C(N=C32)F)N)O)CO |
InChI | InChI=1S/C12H12FN5O3/c1-2-12(4-19)6(20)3-7(21-12)18-5-15-8-9(14)16-11(13)17-10(8)18/h1,5-7,19-20H,3-4H2,(H2,14,16,17)/t6-,7+,12+/m0/s1 |
InChIKey | IKKXOSBHLYMWAE-QRPMWFLTSA-N |
Boiling Point | 669.2±65.0 °C(Predicted) |
Melting Point | 220.0-221.4 °C (dec.) |
Purity | 99.94% |
Density | 1.72±0.1 g/cm3(Predicted) |
Solubility | In Vitro: DMSO : 100 mg/mL(341.01 mM;Need ultrasonic) H2O : 3.57 mg/mL(12.17 mM;ultrasonic and warming and heat to 60°C) In Vivo: 1.Add each solvent one by one:10% DMSO >> 40%PEG300 >> 5%Tween-80 >> 45% saline Solubility: ≥ 2.08 mg/mL (7.09 mM); Clear solution 2.Add each solvent one by one:10% DMSO >> 90% (20%SBE-β-CD in saline) Solubility: ≥ 2.08 mg/mL (7.09 mM); Clear solution 3.Add each solvent one by one:10% DMSO >> 90%corn oil Solubility: ≥ 2.08 mg/mL (7.09 mM); Clear solution 4.Add each solvent one by one:PBS Solubility: 1.35 mg/mL (4.60 mM); Clear solution; Need ultrasonic 5.Add each solvent one by one:5% DMSO >> 40%PEG300 >> 5%Tween-80 >> 50% saline Solubility: ≥ 1.1 mg/mL (3.75 mM); Clear solution 6.Add each solvent one by one:5% DMSO >> 95% (20%SBE-β-CD in saline) Solubility: ≥ 1.1 mg/mL (3.75 mM); Clear solution |
Appearance | White to off-white (Solid) |
Application | Enzyme Inhibitors |
Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
Complexity | 459 |
Exact Mass | 293.09241742 |
Target | HIV; Reverse Transcriptase |
XLogP3-AA | -0.6 |